Tomasz Piec, President of Supervisory Board, Dominik Lipka, PhD Eng., Director of Research and Development, Board Member, and Oskar Szelest, PhD, Business Development Manager, will be attending this year’s RNA Leaders conference. At the event, they will discuss potential opportunities for collaboration in developing encapsulated drugs for pharmaceutically active ingredients, including Lipid Nanoparticles (LNP) for RNA, using various lipid-based formulations. RNA Leaders is a global platform that brings together leading companies involved in RNA-based therapeutics to advance scientific and commercial collaborations and share the latest developments and challenges in the field.